Patricia L Gricus, | |
593 Eddy St, George Clinic, Providence, RI 02903-4923 | |
(401) 444-3201 | |
(401) 444-6115 |
Full Name | Patricia L Gricus |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 593 Eddy St, Providence, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700807740 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT00152 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Patricia L Gricus, 593 Eddy St, George Clinic, Providence, RI 02903-4923 Ph: (401) 444-3201 | Patricia L Gricus, 593 Eddy St, George Clinic, Providence, RI 02903-4923 Ph: (401) 444-3201 |
News Archive
Phylonix Pharmaceuticals announced, at the Society of Toxicology Annual Meeting in Baltimore, that the U.S. Patent and Trademark Office has issued the company a broad patent for assessing the toxicity of pharmaceutical test agents on cardiovascular functions in zebrafish.
Curis, Inc. announced today that it has priced a registered direct offering of 6,449,288 units, at a price of $2.52 per unit, for gross proceeds of $16.25 million before deducting placement agents' fees and estimated offering expenses. Each unit consists of one share of the company's common stock and a warrant to buy 0.25 of a share of the company's common stock. The warrants will be exercisable for a period of five years beginning on the date of issuance, at an exercise price of $3.55 per share.
Saint Louis University's Center for Vaccine Development is studying an investigational vaccine for yellow fever, a potentially deadly disease that is spread by the same mosquito that transmits Zika virus.
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.
› Verified 9 days ago
Caitlin Kelly, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Allison Marie Hourahan, OTR/L, CLT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 668 Eddy St, Providence, RI 02903 Phone: 401-274-1122 | |
Ms. Diana Navarro, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 353 Blackstone Blvd, Providence, RI 02906 Phone: 401-273-6565 | |
Mrs. Kelly L. Klampert, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Kristen Laurie Bourque, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9165 Fax: 401-533-9105 | |
Miss Christa N Fadden, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-8661 | |
Miss Melissa Anne Barlow, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 401-793-5080 |